Discover open access scientific publications

(479) a Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Single Ascending-Dose Study to Evaluate the Safety and Efficacy of Naldemedine in Patients With Chronic Non-Cancer Pain and Opioid-Induced Bowel Dysfunction